Agape ATP Corporation (NASDAQ:ATPC – Get Free Report)’s stock price traded down 5.9% during trading on Monday . The company traded as low as $2.07 and last traded at $2.08. 25,911 shares were traded during trading, a decline of 51% from the average session volume of 52,765 shares. The stock had previously closed at $2.21.
Analyst Ratings Changes
ATPC has been the topic of several research analyst reports. Wall Street Zen raised Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a research note on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, According to MarketBeat, Agape ATP presently has an average rating of “Sell”.
Read Our Latest Research Report on ATPC
Agape ATP Stock Down 3.2%
Agape ATP (NASDAQ:ATPC – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.33) EPS for the quarter. The business had revenue of $0.27 million during the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC lifted its position in shares of Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is owned by institutional investors and hedge funds.
About Agape ATP
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Further Reading
- Five stocks we like better than Agape ATP
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
